A Phase 4 interventional study of Minocycline vs Lymecycline in Mild to Moderate Acne, sponsored by Darier. Status unknown at 1 site in Mexico. Open to participants aged 14 Years to 30 Years. Per ClinicalTrials.gov, last updated 2009-10-01.
Sponsored by Darier · Phase 4, Interventional, and Treatment
This is a clinical trial to compare the benefits and possible adverse events of two antibiotic treatments for mild to moderate acne. It is expected that minocycline microgranules will be more effective than lymecycline with a better adverse events profile.
730 studies on the registry are indexed under Acne Vulgaris; 86 are open to participants now.
This study's planned enrollment of 168 is above the median of 69 across 628 interventional studies indexed under Acne Vulgaris.
Browse Acne Vulgaris studies →This is the only study on the registry with Darier as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Minocycline
Drug: Minocycline vs Lymecycline
Group B: Lymecycline
Drug: Minocycline vs Lymecycline
Minocycline 100 mg OD per mouth for 8 weeks. Lymecycline 300 mg OD per mouth for 8 weeks.
Number of inflammatory and non-inflammatory acne lesions
Time frame: 8 weeks
Incidence of local and systemic adverse events
Time frame: 8 weeks
This study is status unknown, as verified in Sep 2009. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.